Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week phase 2a study of CE-326,597 for glycemic control and body weight in overweight adults with type 2 diabetes mellitus
2007-004891-38Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and obesity comparing CE-326,597 with Placebo (2 arms). Primary endpoint: Change in HbA1c. Started Dec 2007; status: completed.
02
Drugs
CE-326597
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on 2007-004891-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004891-38.